Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Dalian Xinshengyuan Pharmaceutical is a prominent Chinese pharmaceutical company specializing in the development and large-scale manufacturing of amino acid-based therapeutics and parenteral nutrition products. Founded in 1999, the company has established itself as a leader in the production of high-quality amino acid raw materials and finished dosage forms, particularly intravenous infusions. Their product portfolio includes various compound amino acid injections tailored for specific patient populations, such as those with hepatic or renal impairment. Xinshengyuan operates modern manufacturing facilities that adhere to national Good Manufacturing Practice (GMP) standards, ensuring the supply of essential biochemical drugs across China and international markets. In addition to nutrition, the company explores applications in respiratory and metabolic health through its biochemical research and development initiatives.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Dalian Xinshengyuan Pharmaceutical.